Rosacea Triggers: A Functional Medicine Investigation

Rosacea affects 16 million Americans, primarily fair-skinned women between 30-60. The conventional approach — topical metronidazole, azelaic acid, or low-dose doxycycline — manages symptoms but rarely resolves the condition. Most patients cycle through treatments indefinitely.

Functional medicine asks the uncomfortable question: what's actually causing the inflammation? The answers often have nothing to do with the skin.

SIBO: The Gut Connection

The most compelling root cause evidence for rosacea involves small intestinal bacterial overgrowth (SIBO). In a pivotal Italian study, 46% of rosacea patients tested positive for SIBO compared to just 5% of matched controls (Parodi et al., 2008).

When SIBO-positive rosacea patients were treated with rifaximin (a non-absorbed antibiotic that targets the small intestine), 71% showed marked improvement or complete resolution of rosacea. Critically, patients whose SIBO recurred saw their rosacea return — establishing a clear temporal relationship between gut bacterial overgrowth and skin inflammation.

The proposed mechanism: bacterial overgrowth in the small intestine produces endotoxins (LPS) that enter circulation through a compromised intestinal barrier. These endotoxins activate innate immune pathways and toll-like receptor 2 (TLR2) in facial skin — the same receptor implicated in rosacea's inflammatory cascade. The face's dense vascular network and thin skin make it particularly vulnerable to circulating inflammatory triggers.

H. pylori

Helicobacter pylori — the stomach bacterium that causes ulcers — has been linked to rosacea in multiple studies. A meta-analysis found significantly higher H. pylori prevalence in rosacea patients compared to controls. More importantly, several studies show that H. pylori eradication improved rosacea symptoms, with some patients achieving complete remission (Jørgensen et al., 2017).

The mechanism may involve H. pylori's production of cytotoxin-associated gene A (CagA) protein, which triggers systemic inflammation, and its effect on gastrin production, which influences facial vasodilation.

Demodex Mites

Demodex folliculorum and Demodex brevis are microscopic mites that live in hair follicles and sebaceous glands. Everyone has them. But rosacea patients have 5-10 times the density of demodex mites compared to healthy controls, and the density correlates with symptom severity (Forton & De Maertelaer, 2017).

Demodex trigger inflammation through multiple pathways:

• Physical damage to follicular epithelium as they burrow
• Release of bacterial endosymbionts (Bacillus oleronius) that activate TLR2
• Immune response to mite proteins and waste products
• Blockage of sebaceous glands leading to inflammatory papules

Treatment: ivermectin cream (Soolantra) is FDA-approved for rosacea and works primarily through anti-demodex action. Oral ivermectin (single dose or short course) can address severe demodex overgrowth. Tea tree oil (5% applied diluted) has anti-demodex properties.

The Innate Immune System: Cathelicidins

A breakthrough in rosacea research was the discovery that patients have abnormally elevated cathelicidin LL-37 — an antimicrobial peptide of the innate immune system. In rosacea, cathelicidins are cleaved by elevated kallikrein 5 (KLK5) into pro-inflammatory fragments that trigger vasodilation, leukocyte infiltration, and angiogenesis (Yamasaki et al., 2007).

What activates this pathway? UV exposure, demodex mites, bacterial products from SIBO, and vitamin D dysregulation all upregulate cathelicidin production. This is where the internal and external triggers converge in a common inflammatory mechanism.

Additional Triggers and Modifiers

Histamine intolerance: Reduced diamine oxidase (DAO) activity leads to histamine accumulation, which causes vasodilation and flushing. Common in rosacea patients. Histamine-rich foods (wine, aged cheese, fermented foods, cured meats) trigger flares through this pathway.

Hormonal factors: Rosacea commonly worsens around perimenopause, suggesting estrogen decline plays a role. Hot flashes and rosacea flushing share neurovascular pathways.

Stress and autonomic dysfunction: Emotional stress triggers flushing through sympathetic nervous system activation. Rosacea patients show altered autonomic reactivity with exaggerated vasomotor responses.

A Functional Medicine Protocol

1. Test for SIBO (lactulose breath test) — treat with rifaximin or herbal antimicrobials (berberine + oregano oil + neem) if positive
2. Test for H. pylori (stool antigen or breath test) — eradicate if positive
3. Assess demodex density — standardized skin surface biopsy (your dermatologist can do this) — treat with topical ivermectin or tea tree oil
4. Eliminate dietary triggers — alcohol, spicy food, hot beverages, high-histamine foods, dairy (3-4 week elimination)
5. Heal the gut — L-glutamine, zinc carnosine, targeted probiotics
6. Anti-inflammatory support — omega-3s (2-3g EPA+DHA), curcumin, green tea extract (EGCG reduces cathelicidin activation)
7. Topical calming — azelaic acid 15-20% (anti-inflammatory + anti-demodex), niacinamide 4-5%, and a gentle barrier-repair moisturizer

When to See a Practitioner

If topical treatments aren't controlling your rosacea, or if you're tired of indefinite antibiotic courses, a functional medicine investigation is warranted. The combination of SIBO testing, H. pylori screening, and demodex assessment covers the three most treatable root causes. A practitioner who understands the gut-skin axis can build a protocol that addresses why your face is inflamed — not just suppress the inflammation month after month.